A major breakthrough in cancer study is emerging with the use of mini-antibodies to restore damaged p53. This crucial malignant inhibitor protein is frequently disabled in several types of malignancies, leading https://mediajx.com/story307596/vhh-fragments-revive-tumor-suppressor-p53-new-potential-approach-for-malignant-therapy